Document is current
Any future updates will be listed below
-
Authors
Boulouis, Caroline
Kammann, Tobias
Cuapio, Angelica
Parrot, Tiphaine
Gao, Yu
Mouchtaridi, Elli
Wullimann, David
Lange, Joshua
Chen, Puran
Akber, Mira
Rivera Ballesteros, Olga
Muvva, Jagadeeswara Rao
,
Sällberg Chen, Margaret
Healy, Katie
Sobkowiak, Michal
Söderdahl, Gunnar
Blennow, Ola
Österborg, Anders
Mielke, Stephan
Hansson, Lotta
Ljungman, Per
Norlin, Anna-Carin
Wahren-Borgström, Emilie
Bogdanovic, Gordana
Muschiol, Sandra
Hellgren, Fredrika
Loré, Karin
Smith, C. I. Edvard
Vesterbacka, Jan
Kieri, Oscar
Nowak, Piotr
Bergman, Peter
Buggert, Marcus
Ljunggren, Hans-Gustaf
Aleman, Soo
Sandberg, Johan K. https://orcid.org/0000-0002-6275-0750
-
Funding
Funding for this research was provided by:
Vetenskapsrådet
Cancerfonden
Hjärt-Lungfonden
CIMED
Science for Life Laboratory
Karolinska Institutet
Nordstjernan
Region Stockholm
Karolinska Institute
- License Information
-
More Information
Article History
Received: 18 February 2022
Accepted: 25 April 2022
First Online: 13 May 2022
Declarations
:
: The study was approved by the Swedish Medical Product Agency (ID 5.1-2021-5881) and the Swedish Ethical Review Authority (ID 2021-00451). All participants provided written informed consent.
: Not applicable.
: The authors declare that they have no competing financial interests, patents, patent applications, or material transfer agreements associated with this study. M.B. is a consultant for Oxford Immunotec. S.A. has received honoraria for lectures and educational events, not related to this work, from Gilead, AbbVie, MSD, Biogen and Netdoktor.
